Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Liver Cirrhosis

Free Subscription 26.01.2026 1 BMC Gastroenterol 1 Clin Res Hepatol Gastroenterol 2 Hepatology 1 Intern Med 2 J Hepatol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. XU X, Li J, Yu H, Huang J, et al
   Interpretable model for early prediction of 28-day mortality in patients with cirrhosis and sepsis: a multi-cohort ICU study.
   BMC Gastroenterol. 2026 Jan 20. doi: 10.1186/s12876-026-04620.
   PubMed        
   
   

   
   Clin Res Hepatol Gastroenterol

2. LEPOUR M, Delorme A, Goffaux A, Trefois P, et al
   Low muscle density and Five Times Sit-to-Stand Test predict poor outcome in liver transplant candidates.
   Clin Res Hepatol Gastroenterol. 2025 Dec 10:102743.
   PubMed         Abstract available
   
   

   
   Hepatology

3. ZHANG P, Liu D, Wu L, Wu X, et al
   Neutrophil serine proteases NE and PR3 controlled by the miR-223/STAT3 axis potentiate MASH and liver fibrosis.
   Hepatology. 2026;83:317-332.
   PubMed         Abstract available
   
   
4. ZHAO Q, Liu H, Yang Z, Han X, et al
   Pre-B-Cell leukemia transcription factor 1 contributes to liver fibrosis by enabling IL-7 signaling in hepatic stellate cells.
   Hepatology. 2025 Mar 13. doi: 10.1097/HEP.0000000000001302.
   PubMed         Abstract available
   
   

   
   Intern Med

5. KITAO T, Tanaka T, Kubori M, Komoda Y, et al
   Evaluation of the Short-term Effect of Pemafibrate on Liver Fibrosis Biomarkers Stratified by FIB-4 Index in Patients with Type 2 Diabetes Mellitus and Hypertriglyceridemia.
   Intern Med. 2026;65:252-261.
   PubMed         Abstract available
   
   

   
   J Hepatol

6. WONG YJ, Lam L, Soret PA, Lemoinne S, et al
   Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis.
   J Hepatol. 2025 Oct 3:S0168-8278(25)02519-X. doi: 10.1016/j.jhep.2025.
   PubMed         Abstract available
   
   
7. ZHOU XD, Lian LY, Chen QF, Kim SU, et al
   Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.
   J Hepatol. 2026;84:254-265.
   PubMed         Abstract available
   
   

   
   PLoS One

8. SU T, Lai S, Chen H
   Intestinal decontamination with rifaximin attenuates LSEC dysfunction and liver fibrosis in mice.
   PLoS One. 2026;21:e0340664.
   PubMed         Abstract available
   
   
9. TOH C, Sanit K, Sripongpun P, Chamroonkul N, et al
   Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study.
   PLoS One. 2026;21:e0341366.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.